Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Determining the effect of Cupping on nonspecific lumbar pain of the elderly referred to the Iranian Medicine Clinic of Kerman University of Medical Sciences
Design:
This clinical trial was designed with 70 patients in two groups of cupping therapy and placebo by a simple random method for 10 days, into every other day in even or odds day to avoid patients of two groups confronting each other. the patients record their probably complications and pain intensity based on vas questionnaire from 0-10 in checklist.
Settings and conduct:
This study is designed for elderly patients with non-specific low back pain in Kerman traditional Persian medicine clinic.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Willingness and satisfaction of the patient to participate in the study
The presence of non-specific musculoskeletal pain in the lower back based on the doctors diagnosis
Age>60 years (35)
Mild to moderate pain intensity 4-8 on VAS Low back pain>=3 month (8)
BMI <35 (34)
Exclusion criteria: Back pain caused by trauma inflammatory or malignant disease
Presence of coagulopathy disease or anticoagulant agent consumption
Existence of radiculopathy symptoms such as radiating pain, paresis, prickling, or tingling of lower limb
Serious acute or chronic organic disease such as diabetes, mental disorders
Congenital malformation of the spine
Treatment with physiotherapy or opiates and other procedures within the last 4 weeks
Central Nervous System impairment
Intervention groups:
This study is an interventional research as a clinical trial. The first group is undergoing cupping therapy and the second group received placebo with slight negative pressure and Double-sided adhesive.
Main outcome variables:
pain intensity VAS Questionnaire (0-10)